Samantha Du Retires as CEO of Hutchison MediPharma

Samantha Du, PhD has quietly retired as CEO of Hutchison MediPharma and Chief Scientific Officer of its parent, Hutchison Chi-Med. She plans to take a few months off while she evaluates her next career move. Dr. Du is a true pioneer in China’s progress to novel drug development. In the early 2000s, she convinced Hutchison Whampoa to launch a drug development company when the West believed there was no novel drug development in China. She proved everyone wrong. More details.... Stock Symbol: (AIM: CHM)     Share this with colleagues: